How the CRISPR Gene Editing Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the CRISPR Gene Editing Market?
The escalating incidence of genetic disorders is anticipated to fuel the expansion of the CRISPR gene editing market in the future. Genetic disorders result from genome irregularities, such as mutations in either a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. Factors like genetic mutations, aging population, and marriages within close relatives contribute to the rise in genetic disorders. Effective management of genetic disorders is facilitated by CRISPR gene editing through accurate and targeted alterations to the DNA. Additionally, scientists employ CRISPR to pinpoint and rectify specific mutations responsible for genetic disorders, restore regular function, and mitigate disease symptoms seen in conditions like cystic fibrosis and sickle cell anemia. For example, in July 2022, the Cystic Fibrosis (CF) Foundation, a non-profit organization based in the US, reported an increase in cystic fibrosis cases. In 2022, nearly 40,000 children and adults in the United States, and over 105,000 people globally were diagnosed with cystic fibrosis. As such, the escalating incidence of genetic disorders fuels the expansion of the CRISPR gene editing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp
#How Will the CAGR of the CRISPR Gene Editing Market Influence Its Overall Growth by 2034?
The market size of CRISPR gene editing has witnessed tremendous growth over the recent years. The market, which had been worth $2.26 billion in 2024, is forecasted to escalate to $2.88 billion in 2025, with a compound annual growth rate (CAGR) of 27.4%. Factors such as growing demand for genome editing technologies, an increase in government funding, rise in cancer incidences, growing cases of chronic diseases, heightened awareness about CRISPR technology and improved healthcare infrastructure have contributed to the growth in the historic period.
Expectations are high for the CRISPR gene editing market size to experience a significant surge in growth in the upcoming years. The market is projected to expand to $7.51 billion by 2029, boasting a compound annual growth rate (CAGR) of 27.1%. Factors contributing to this predicted growth in the forecast period include an increased occurrence of genetic disorders, a heightened focus on precision medicine, a rise in investment in CRISPR research and development, an escalating elderly population, and an increasing prominence of gene therapy procedures. Key emerging trends for the forecast period encompass advancements in gene editing technology, growth in the number of research studies, progress in drug discovery and development, innovation in delivery methods, and the uptake of CRISPR-edited agriculture.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15549
What Are the Most Significant Market Trends Transforming theCRISPR Gene Editing Market?
Leading corporations in the realm of the CRISPR gene editing market are staging efforts to create innovative products like gene therapy, with aims to expand their customer reach, boost sales, and amplify revenue. Gene therapy is a form of medical approach that employs genes for the prevention, treatment, or even curing ailments and disorders. For instance, in December 2023, Casgevy, a cell-based gene therapy, received approval from the US Food and Drug Administration (FDA), a federal agency in America, for its use in combating sickle cell disease. This therapy involves the use of CRISPR/Cas9, a form of genome editing technology. Utilizing this technology, hematopoietic stem cells undergo modifications.
What Are the Top Market Players Propelling the Growth of theCRISPR Gene Editing Industry?
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Which Primary Segments of the CRISPR Gene Editing Market Are Driving Growth and Industry Transformations?
The CRISPR gene editing market covered in this report is segmented –
1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies
Subsegments:
1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9, Cas12, Cas13, Other Cas Nucleases
2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA), Dual-guide RNA, Synthetic Guide RNA
3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase, E. coli DNA Ligase, Other DNA Ligases
4) By Restriction Endonuclease: Type II Restriction Enzymes, Type I And III Restriction Enzymes, Other Restriction Enzymes
5) By Other Types: CRISPR Delivery Systems, CRISPR Plasmids, CRISPR-Based Diagnostic Tools
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the CRISPR Gene Editing Market?# Market?
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global CRISPR Gene Editing Market 2025, By The Business Research Company:
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Plant Breeding And CRISPR Plants Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
